Objectives: To investigate the attributes of Australian clinical quality registries (CQR). Design and setting: Survey of 40 CQRs between September 2015 and April 2016. Participants: CQR lead investigators/project managers. Intervention: None. Main outcome measures: Registry organization, geographical coverage, data quality, management, characteristics, output and outcomes. Results: Of those who responded (34/40; 85.0%), 12 (34.3%) were binational (Australia and New Zealand); 22 (64.7%) were Australian-only registries; and 13 (38.2%) had national coverage. CQRs covered critical care, infection control, cardiovascular diseases, cancer, chronic diseases, procedures and devices, and transplants. Overall, 24/34 CQRs (70.6%) were public sector funded. In total, 14 (41.2%) scored >75% on a composite score developed to assess data quality. Overall, 29/ 34 (85.3%) produced an annual multi-centred report; only 15/34 (44.1%) produced provider-specific reports. Mortality/survival and quality of life were collected by 82.4 and 32.4% of CQRs, respectively. Most CQRs displayed data in bar/column charts (28/34, 82.4%) and funnel plots (17/34, 50%). Most CQRs adopted an opt-out consent process (n = 17/31; 54.8%). Linear regression indicated that longer duration of CQR was associated with higher data quality (>20 vs 0-5 years coefficient = 4.76, 95% CI: 0.26, 9.26). Opt-in consent was associated with lower data quality (no active consent vs opt-in approval method, coefficient = −5.22, 95% CI: −8.71, −1.72). Six CQRs self-reported having undertaken an economic evaluation of their registry. Conclusion: CQRs varied in geographical coverage; stage of development, approach to recruitment; method and frequency of reporting their output; and data quality assurance. An accreditation system for CQRs would likely assist in recognizing high-quality registries.
Introduction
Healthcare expenditure in Organization for Economic Co-operation and Development (OECD) countries is increasing due to the introduction of advance medical technology, pharmaceutical expenditure, hospital care and the high prevalence of chronic diseases and their financial consequence [1] [2] [3] . This has created a need to implement systems to improve the efficiency and quality of health care [4] . In Australia health expenditure has increased from $50.3 billion in 1989-90 to $161.6 billion in 2014-15 and the gross domestic product (GDP) spent on healthcare has risen from 6.5% to 10% of GDP during the same period [5, 6] . To improve cost-effectiveness clinical quality registries (CQRs) have been established.
CQRs collect a defined minimum data set from patients undergoing a particular procedure, diagnosed with a disease or using a healthcare resource. They systematically capture data from existing administrative systems, medical records or directly from clinical staff or patients using data collection forms [4] . CQRs are described in the Sweden Health Act as 'an automated and structured collection of personal data that were initiated with the purpose to systematically and continuously develop and safeguard quality of care' [7] . They aim to capture longitudinal health outcomes on close to the entire eligible population being studied, with reports assessing health outcomes being risk-adjusted to account for factors over which the treating hospital has little or no control [8] . CQRs assist in identifying where best practice and variation in treatments and outcomes exist. If used effectively, CQRs can result in better health outcomes [9, 10] . National CQRs have been proposed as important tools to address gaps in the relevance and effectiveness of health care in Australia [8] .
A key attribute of CQRs is that they provide feedback to stakeholders including clinicians, managers, funders, policy makers and researchers to benchmark and identify significant variation in quality of care. Registries often provide feedback via annual reports and, less often via provider-specific reports [11] .
In Australia, the number of known CQRs has grown from 28 in 2006-7 [11] to 37 in 2012. [12] . Given the 30% growth over this 5-year period, the aim of this project was to understand the attributes of contemporary CQRs in Australia, and factors associated with welldesigned registries achieving a high level of population coverage.
Methods

Study design and settings
A cross-sectional design was adopted and a survey questionnaire was emailed to registry custodians, managers or principal investigators across Australia. The survey tool that was used for data collection was adapted from the tools developed by Black et al. [13] and Evans et al. [11] for an Australian context. We adopted a broad definition of a CQR; including registries which systematically collected patient-level data on an ongoing basis and directly reported on quality of care and health outcomes to health services.
Study population
A review of the Medline database (January 1996-September 2015) and a web-based search of the grey literature was undertaken using the key words: registries, clinical, Australia, Victoria, Queensland, Western Australia, South Australia, New South Wales, Tasmania and Northern Territory. Studies were limited to English language and human studies. To capture registries which may not have yet published their data or methodology, we communicated with the national Registry Special Interest Group [14] , a peer-support group for researchers and clinicians managing or operating registries. We requested that they append any additional registries to the list obtained from the literature review ( Supplementary Fig. S1 ). 
Inclusion and exclusion criteria
We included registries that collected data from more than one hospital; were operating in Australia or Australia and New Zealand; described either a clinical registry or a CQR which collected data on a procedure, disease condition or treatment for a particular condition; were collecting data systematically on an ongoing basis from the population being investigated and were providing some level of reporting to hospitals. The content of reports generated by the registry was kept broad and included measurement of patterns of treatment and/or performance against quality indicators.
Data collection
Each registry was contacted prior to distribution of the survey to identify the most appropriate primary contact person to complete the survey. This person was generally the operational or clinical registry leader, data custodian or project manager. An explanatory statement, consent form and the survey instrument were emailed to each CQR primary contact person. Instructions were provided to consent first then complete the survey and return in an enclosed, stamped addressed envelope. Follow-up telephone calls were made to respondents to clarify responses where necessary.
Assessment of CQR data quality
A grading system was developed to assess the quality of registries in regard to their population coverage and data quality (Table 1) . A score was given to responses to the following six categories, ranging from 1 (lowest level) to 4 (highest level):
(I) completeness of recruitment of eligible population; (II) reliability of coding conditions and interventions; (III) level of data validation; (IV) independence of observations of primary outcomes; (V) completeness of data; and (VI) the percentage of variables which had clear definitions laid out in a document.
The results to each of these six categories were summed and converted to a percentage to create a composite score. Where responders failed to respond to the question, it was removed from the calculation. The overall quality of registries was ranked as poor (overall quality score <50%), good (50-75%), very good (76-85%) or excellent (>85%) (Box 1).
Data analysis
We conducted descriptive analyses of the registry attributes, including the diseases and/or clinical areas they covered, their organization and management structure, geographical coverage, source of funding, how data security and confidentiality were managed, what the databases were used for (including whether any assessment of the return on investment in the registry had even been undertaken), and the quality of the data, feedback mechanism and frequency of feedback. We conducted a univariate and multivariate linear regression using the step wise likelihood ratio probability of removal set at 5% with the composite data quality score for each registry as the dependent variable. We estimated the coefficient for each of the following predictor variables: duration of the registry, geographical coverage, consent process, types of registry and funding. Statistical analysis of the data was conducted using the STATA (version 13.0, StatCorp, College Station, TX, USA).
Ethical considerations
This study was approved by the Monash University Human Research Ethics Committee (approval number CF15/1672-2015000838).
Results
We identified 40 Australian CQRs, 21 through the literature review and 19 through contact with the national Registry Special Interest Group. Of these, we received responses from 34 (response rate of 85.0%) (see Box 2) . Table 1 describes the organization, geographical coverage and management of the CQRs. A total of 12 (34.3%) had coverage in Australia and New Zealand, including two which also had coverage of other countries, while 22 (64.7%) had geographical coverage only in Australia. Of all CQRs surveyed, half had been operational for more than a decade. More than half had reported enrolment of at least 10 000 episodes or patients. While all CQRs had a Steering Committee, the frequency with which they met ranged from annually to five times per year. Most were funded through multiple funding sources, with the most frequent funder being the public sector (70.6%), and 26.5% being funded via research grants. Overall, 27 (79.4%) registries had formal approval for their database from their relevant professional body. Characteristics of the registries are described in Table 2 and  Supplementary Table S1 . While most (31/34 = 91.2%) had a data dictionary to ensure a systematic and identical approach to data collection and data entry, only 20/34 (49.8%) assessed whether their data elements were consistent with those defined in the national data dictionary. An opt-in consent process was used for seven (20.6%) registries, while 17 (50.0%) adopted an opt-out consent process whereby patients were included in the registry unless they A summary of composite score results is outlined in Fig. 1 . Overall, 10 registries (29.4%) were regarded as excellent, 4 as very good (11.8%), 17 as good (50.0%) and 3 (8.8%) were of low quality ( Fig. 1 and Supplementary Table S3 ). Overall 14 (41.2%) registries scored >75% on a composite score developed to assess data quality.
Further assessment of coverage, reliability and validation are described in Supplementary Tables S1 and S2. In total, 64.7% (22 registries) of the databases recruited at least 90% of the eligible population. Among those registries, 12 registries (12/22) adopted an opt-out consent process and four registries (4/22) an opt-in consent process. Treating physicians were responsible for recording outcomes in 67.6% of the registries and by trained data collectors in 52.9% of the registries (Supplementary Table S2) . Table 3 describes the reported output and outcomes collected by Australian CQRs. Most registries (n = 29, 85.3%) produced a multicentred report annually which was sent out to providers and other interested parties, such as funders. Only 44.1% (n = 15) produced provider-specific reports, defined as reports produced by the registry for individual health care providers who submit data to the database and which contain either results of the analysis of the data from that provider, or which include comparison with other providers. Most (n = 28, 82.4%) reported mortality/survival data as a primary outcome; with 67.6% (n = 23) collecting complications and 32.4% (n = 11) collecting quality of life data. Of the 28 registries reporting mortality and quality of life, 14 (50%) reported this using a funnel/scatter plot and 8 (28.6%) reported using time series analyses. Cancer, cardiovascular and critical care registries were significantly more likely to use funnel plots and time series than those monitoring devices or procedures (23/28 vs 1/5, P = 0.013 Fishers exact test) (data not shown). Only six registries reported having undertaken an analysis to determine their registry's return on investment. Table 4 summarizes the association between CQR attributes and the composite score. In the fully adjusted model, factors associated with having a high composite score (and hence a high-quality registry) were time period covered by the registry and consent method used on recruitment. Registries operating for >20 years were of a higher quality than those in operation for <5 years (coefficient = 4.76, 95% CI: 0.26, 9.26, P = 0.039). An opt-in consent process was associated with lower data quality (no active consent vs opt-in approval method, coefficient = −5.22, 95% CI: −8.71, −1.72, P = 0.005). Though in unadjusted model we found significant association of clinical registries with device registries (coefficient = −3.63, 95% CI: −7.11, −0.15) but when adjusted we could find any significant association.
Discussion
In this study we investigated the characteristics of CQRs, providing an update on registry development in Australia. Over the past 8 years, there has been a 42% increase in the number of CQRs. New registries have been developed to monitor surgical, cancer and critical care and the scope of coverage has increased. There has been a 2-fold increase in registries, now having national coverage, from 5/ 28 (17%) in 2007 to 14/34 (41.2%) in 2016.
We found almost three quarters (70.5%) of registries were funded at least in part by the public sector and that 26.5% were funded through research grants. While grants are instrumental in assisting registries in their development, they rarely provide stability in the medium to longer term. Registries take time to mature and achieve a high level of capture, in part because of required ethics and governance processes in their establishment phase [15] . A sustained and appropriate level of funding is required to allow registries sufficient time to reduce manual data collection, harness data linkage capability and include as a matter of course appropriate data quality control checks [16] .
We found consent processes for data collection varied between registries. Consent models appeared to reflect the complexity and prevalence of the diseases they capture. Rare and chronic conditions such cystic fibrosis chose to adopt an opt-in approach while registries monitoring more prevalent conditions, e.g. trauma, massive transfusion and cancer, used an opt-out or waiver of consent approach. In total, registries using an opt-out approach were three times more likely to have recruited more than 90% of the eligible population compared to those using an opt-in approach (54.5 vs 18.2%). Tu et al. [17] has outlined the impact of using an opt-in consent model, which includes risk of selection bias and threats to privacy, as well as requirement for additional financial resources. They recommended for legislation on privacy and policies for waivers of informed consent for minimal-risk observational research. Our finding that opt-out registries and those not requiring opt-in consent are of a higher quality support this recommendation. In Sweden where the government has invested heavily in quality registries [17] , the law states that there is no requirement for consent from individuals. Instead, the patient has the right to opt-out of the registry at any time and request that their data be erased [18] . A review of reports submitted by 103 Swedish registries has identified a lower overall data completeness rate than that reported by our registries (60 vs 80% reporting >80% of fields are complete). While both our study and that by Emillson et al. relied on self-reports, the Swedish study also included an independent review of annual reports, which we did not undertake.
Quality control checks within registries were variable. Areas of concern relate to the low number of registries assessing reliability of data and that half of the registries relied on a person who was neither blinded nor independent to the treatment documenting the primary outcome under investigation. It is sub-optimal to have the clinician responsible for the care also responsible for assessing outcomes as this may result in selection and reporting bias. The most effective strategy to reduce this potential bias is having clinical and outcome data collected by an independent third party. Another less ideal approach would be to undertake an independent random audit of data. Patient-reported outcome assessment is increasingly being recognized as providing important information on the success of treatment if undertaken on a representative sample of patients and using validated instruments [22] . Disappointingly, we found that only one third of CQRs were collecting patient-reported quality of life. There is good evidence that audit and feedback are effective in changing practice [23] . Timeliness, frequency, confidentiality, trust in data quality, case-mix factors, level of data aggregation and ease of implementation are all related to the effectiveness or success of feedback. Feedback initiatives can be multifaceted, including components such as clinical education, support with analysing, discussion process and educational meetings on the interpretation of feedback [23] . In our survey output reporting from registries was principally via providerspecific and multi-centre annual reports. The number of registries providing on-demand provider-specific reports has doubled since our last survey in 2007 from 6/28 (21%) to 14/34 (41.2%) in 2016.
We found only six registries had reported conducting economic analyses to assess the value of the registry. It is incumbent of registries to demonstrate their value. Recently the Australian Commission on Safety and Quality in Health Care assessed the economic impact of five Australian CQRs, four of which were reported in our survey. The evaluation concluded that in general, CQRs provided a significant net positive return on investment, with benefit to cost ratios ranging from 2:1 to 7:1 for five different registries [24] . However, not every clinical quality registry may be cost-effective and problems such as low coverage, inadequate or biased reporting and inadequate collection of information about patient outcomes will limit their value [24] . Australian CQRs may benefit from receiving support to undertake economic evaluations.
Our study has some limitations. Six registries declined to participate in the survey, so we cannot report on their quality. As this is a self-reported survey, it is possible that respondents did not accurately record the attributes of their registry. In addition, while we asked respondents to outline their governance arrangements, we did not assess the quality of the committees monitoring the registry, including whether they had structures and processes in place to deal with outliers and unexplained variance. We also only assessed whether data elements collected by the registries were defined by the Australian national data dictionary (METeOR). It may be that some registries chose to align their data definitions with international databases rather than METeOR. However, having nationally consistent data definitions enables greater capacity for data linkage within Australia and is encouraged when registries are developed [25] .
Conclusions
Our study suggests that there would be benefit in establishing an accreditation system for registries and providing assistance to enable registries to function to their full potential. Gaps in current practice involving assessing data reliability likely reflect the limited resources available to registries to undertake this important quality assurance activity. Removing barriers to recruitment will go some way towards assisting registries, but greater support to automate collection of high quality data, facilitate data linkage of high-quality data, assess on an ongoing scheduled basis data quality and develop sophisticated reporting platforms will optimize their ability to provide value for money.
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